Many authors underline that the delay in the initiation of the treatment may negatively affect the prognosis, and thus, it should be started when c-ANCA levels are elevated and clinical picture strongly suggests GPA [19]. The gene discussed is PRTN3; the disease is granulomatosis with polyangiitis.